ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "Economics"

  • Abstract Number: 360 • 2019 ACR/ARP Annual Meeting

    Colchicine Prophylaxis of Gout Flares When Commencing Allopurinol Is Very Cost Effective: A Health Economic Analysis

    Philip Robinson1, Nicola Dalbeth 2 and Peter Donovan 3, 1University of Queensland, Brisbane, Queensland, Australia, 2University of Auckland, Auckland, New Zealand, 3University of Queensland, HERSTON, Australia

    Background/Purpose: Prophylaxis of acute gout flares when commencing urate lowering therapy is recommended by international guidelines. Whether this is a cost-effective intervention is currently unknown.…
  • Abstract Number: 1113 • 2019 ACR/ARP Annual Meeting

    Improving Healthcare Quality and Reducing Cost via Online Interaction for Chinese Patients with Rheumatic Diseases Based on Smart System of Disease Management (SSDM) Mobile Tool

    Hua Wei1, Anbin Huang 2, Li Luo 3, Fen Wang 4, Qin Li 5, Hong Zhang 6, Yong Wang 7, Peng Ji 3, Yanping Zhao 8, LingXun Shen 9, Zhengang Wang 10, Feng Wei 11, Tong Xie 12, Xiaohan Wang 13, Huifang Guo 14, Qiang Shu 15, Xiangyuan Liu 16, Rong Du 17, Anbing Zhang 18, Fang Qin 19, Bing Wu 20, Yuhua Jia 21, Hui Xiao 22, Fei Xiao 23 and Fengchun Zhang 24, 1Northern Jiangsu People's Hospital, Yangzhou, China (People's Republic), 2Union Hospital Affiliated Tongji Medical College of Huazhong University of Science and Technolog, Han Wu, Hubei, China (People's Republic), 3The first affiliated hospital of xinjiang medical university, Urumchi, China (People's Republic), 4First Affiliated Hospital of Medical University Of Anhui, Hefei, Anhui, China (People's Republic), 5The First People's Hospital of Yunnan Province, Kunming, Yunnan, China (People's Republic), 6The First People's Hospital of Yunnan Province, Kunming, China (People's Republic), 7The first Hospital Affiliated to AMU (Southernwest Hospital), Chongqing, China (People's Republic), 8First Affiliated Hospital of Harbin Medical University, Harbin, China (People's Republic), 9Union Hospital Affiliated Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China (People's Republic), 10TongRen hospital,Capital University, Bei Jing, China (People's Republic), 11Jiangmen Central Hospital Affiliated Jiangmen Hospital of Sun Yat-Sen University, Jiangmen, China (People's Republic), 12Affiliated hospital of Guangdong medical University, Zhanjiang, Guangdong, China (People's Republic), 13Anyang district hospital, Fuyang, Hainan, China (People's Republic), 14The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China (People's Republic), 15Qilu Hospital of Shandong University, Jinan, China (People's Republic), 16Peking University Third Hospital, Beijing, China (People's Republic), 17Union hospital affiliated to huazhong university of science and technology, Wuhan, China (People's Republic), 18Xiangyang city center hospital, Xiangyang, China (People's Republic), 19The first affiliated hospital of guangxi medical university, Nanning, China (People's Republic), 20Shanghai Gothic Internet Technology Co., Ltd, Shanghai, China (People's Republic), 21Shanghai Gothic Internet Technology Co., Ltd., Shanghai, Shanghai, China (People's Republic), 22Shanghai Gothic Internet Technology Co., Ltd, shanghai, Shanghai, China (People's Republic), 23Shanghai Gothic Internet Technology Co., Ltd., shanghai, China (People's Republic), 24Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China (People's Republic)

    Background/Purpose: Without efficient primary medical care and follow-up system in China, patients can choose any hospital or doctor they like in seeking medical care. As…
  • Abstract Number: 1174 • 2018 ACR/ARHP Annual Meeting

    Comparative Cost per Response for Four Clinical Outcomes of Tocilizumab Monotherapy Versus Adalimumab Monotherapy in a Head-to-Head Randomized Double-Blind Superiority Trial in Patients with Rheumatoid Arthritis

    Jennie H. Best and Jinglan Pei, Genentech, Inc., South San Francisco, CA

    Background/Purpose: The cost-effectiveness of different biologic therapies is an important component in guiding treatment decisions for patients with rheumatoid arthritis (RA). The objective of this…
  • Abstract Number: 1757 • 2018 ACR/ARHP Annual Meeting

    An Economic Systematic Literature Review of Eosinophilic Granulomatosis with Polyangiitis

    Scott Doyle1, Emily Moss2, Louise Hartley2, Chris Knight2, Judith Bell2, Outi Ahdesmäki2 and Maebh Kelly3, 1Value Evidence and Outcomes, GlaxoSmithKline, London, United Kingdom, 2RTI Health Solutions, Manchester, United Kingdom, 3Pope Woodhead, London, United Kingdom

    Background/Purpose: To better understand the available economic evaluations in eosinophilic granulomatosis with polyangiitis (EGPA), a systematic literature review was undertaken. The primary objective of this…
  • Abstract Number: 2183 • 2018 ACR/ARHP Annual Meeting

    Access to Prescription Drugs in Canada: Results from an Online Survey

    Nick Bansback1,2,3, Cheryl L. Koehn4, Judy Chiu5, Melanie Mulder6 and Linda Li1, 1Arthritis Research Canada, Richmond, BC, Canada, 2University of British Columbia, Vancouver, BC, Canada, 3St Paul's Hospital, Centre for Health Evaluation and Outcomes Sciences, Vancouver, BC, Canada, 4Arthritis Consumer Experts, Vancouver, BC, Canada, 5Centre for Health Evaluation and Outcome Sciences, Vancouver, BC, Canada, 6St Paul's Hospital, Vancouver, BC, Canada

    Background/Purpose: Prescription medications are an important treatment option for patients living with arthritis. However, patients may often not have access to certain medications they hear…
  • Abstract Number: 2995 • 2018 ACR/ARHP Annual Meeting

    Healthcare Cost of Potential Glucocorticoid-Associated Adverse Events in Patients with Giant Cell Arteritis

    Jennie H. Best1, Amanda Kong2, David Smith2, Ibrahim Abbass1 and Margaret Michalska1, 1Genentech, Inc., South San Francisco, CA, 2IBM Watson Health, Bethesda, MD

    Background/Purpose: To quantify the healthcare expenditures associated with oral glucocorticoids-related-adverse events (OGCs-AEs), among patients in the US with giant cell arteritis (GCA) using claims data…
  • Abstract Number: 2251 • 2017 ACR/ARHP Annual Meeting

    Preferences for Physical Activity: A Discrete Choice Experiment in People with Chronic Knee Pain

    Daniel Pinto1, Ulf Bockenholt2, Rowland W. Chang3,4, Julia (Jungwha) Lee5, Jane Holl6, Daniel Finn6, Leena Sharma7, Allen Heinemann8 and Paul Hansen9, 1Department of Physical Therapy & Human Movement Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, 2Department of Marketing, Kellogg School of Management, Northwestern University, Evanston, IL, 3Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, 4Preventive Medicine, Medicine, and Physical Medicine & Rehabilitation, Northwestern University Feinberg School of Medicine, Chicago, IL, 5Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 6Center for Healthcare Studies, Northwestern University Feinberg School of Medicine, Chicago, IL, 7Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, 8Center for Rehabilitation Outcomes Research, Shirley Ryan Ability Lab, Chicago, IL, 9Economics, University of Otago, Dundin, New Zealand

    Preferences For Physical Activity: A Discrete Choice Experiment In People With Chronic Knee Pain Background/Purpose: Understanding preferences for physical activity (PA) can help guide patient…
  • Abstract Number: 2497 • 2017 ACR/ARHP Annual Meeting

    The Role of Individual and Country-Level Socio-Economic Factors in Work Participation in Patients with Spondyloarthritis across 22 Countries Worldwide: Results from the Comospa Study

    Santiago Rodrigues Manica1,2, Alexandre Sepriano3,4, Sofia Ramiro5,6, Fernando Pimentel-Santos1,2, Polina Putrik7, Elena Nikiphorou8,9, Anna Moltó10,11, Maxime Dougados11,12, Désirée van der Heijde13, Robert B.M. Landewé14, Filip van Den Bosch15 and Annelies Boonen7, 1CEDOC, NOVA Medical School, Lisbon, Portugal, 2Rheumatology, Hospital Egas Moniz, Centro Hospitalar de Lisboa Ocidental, Lisbon, Portugal, 3CEDOC, NOVA Medical School, Lisboa, Portugal, 4Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 5Rheumatology, Department of Rheumatology, LUMC, Leiden, Netherlands, Leiden, Netherlands, 6R. Câmara Pestana 6, CEDOC, NOVA Medical School, Lisbon, Portugal, 7MUMC+, Maastricht, Maastricht, Netherlands, 8Whittington Hospital, London, United Kingdom, 9Academic Rheumatology Department, King's College London, London, United Kingdom, 10Rheumatology B Department, Paris Descartes University, Cochin Hospital, AP-HP,Paris, Paris, France, 117 INSERM (U1153), Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris, France, 12Paris, Paris, France, 13Leiden University Medical Center, Leiden, Netherlands, 14Clinical Immunology & Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center, Heerlen, Netherlands, 15Rheumatology, Ghent University Hospital, Gent, Belgium

    Background/Purpose: Spondyloarthritis (SpA) carries substantial financial costs, including direct costs (use of medical services and treatments) and indirect costs (loss of work productivity). While disease…
  • Abstract Number: 133 • 2017 ACR/ARHP Annual Meeting

    Impact of the Five Components of the Euroqol 5-Dimensions Instrument on Healthcare and Work-Loss Costs in Rheumatoid Arthritis: Observational Data from Southern Sweden

    Anders Gülfe1, Tor Olofsson1, Jonas K Söderling2, Martin Neovius2 and Johan K Wallman1, 1Department of Clinical Sciences Lund, Rheumatology, Lund University, Lund, Sweden, 2Department of Medicine, Clinical Epidemiology Unit, Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: Healthcare and work-loss costs are markedly higher in RA patients than in the general population. The EuroQol 5-Dimensions (EQ-5D) instrument, commonly applied to measure…
  • Abstract Number: 199 • 2017 ACR/ARHP Annual Meeting

    Incremental Direct Medical Costs of Systemic Lupus Erythematosus Patients in the Years Preceding Diagnosis and the Impact of Sex: A General Population-Based Study

    Natalie McCormick1,2, Carlo Marra3 and J. Antonio Avina-Zubieta4, 1Arthritis Research Canada, Richmond, BC, Canada, 2Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada, 3School of Pharmacy, University of Otago, Dunedin, New Zealand, 4Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada

    Background/Purpose: Little is known about the healthcare costs of systemic lupus erythematosus (SLE) patients in the years leading up to SLE diagnosis.  We estimated the…
  • Abstract Number: 224 • 2017 ACR/ARHP Annual Meeting

    Patterns of Methotrexate Use in African Countries with Low Versus Medium/High Human Development Index: Preliminary Results of Semi-Structured Interviews

    Carol A Hitchon1, Yan Liu2, Steven Shi3, Girish M Mody4, Candace H. Feldman5, Michael Weinblatt6 and Ines Colmegna7, 1Internal Medicine, University of Manitoba, Winnipeg, MB, Canada, 2McGill University, Montreal, QC, Canada, 3University de Montreal, Montreal, QC, Canada, 4Dept of Rheumatology, University of Kwa Zulu-Natal, Durban, South Africa, 5Brigham and Women’s Hospital, Division of Rheumatology, Immunology and Allergy, Boston, MA, 6Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 7Division of Rheumatology, Department of Medicine, Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada, Montreal, QC, Canada

    Background/Purpose: Methotrexate (MTX) is standard therapy for rheumatoid arthritis (RA) and also used to treat other rheumatic diseases. Existing guidelines for RA treatment/ MTX use…
  • Abstract Number: 414 • 2017 ACR/ARHP Annual Meeting

    Multi-Biomarker Disease Activity and Autoantibody Status Lead to Cost Effective Tapering Algorithms in Rheumatoid Arthritis Patients in Sustained Remission

    Melanie Hagen1, Matthias Englbrecht2, Judith Haschka3, Michaela Reiser4, Arnd Kleyer5, Axel J. Hueber6, Bernhard Manger7, Camille Figueiredo8, Jayme Fogagnolo Cobra9, Hans-Peter Tony10, Stefanie Finzel11, Stefan Kleinert12, Joerg Wendler13, Florian Schuch13, Monika Ronneberger13, Martin Feuchtenberger14, Martin Fleck15,16, Karin Manger17, Matthias Schmitt-Haendle18, H.-M. Lorenz19, HG Nüßlein20, Rieke Alten21, Joerg C. Henes22, Klaus Krüger23, Georg Schett2 and Juergen Rech24, 1University of Erlangen-Nuremberg, Erlangen, Germany, 2Department of Internal Medicine 3, University of Erlangen-Nuremberg, Erlangen, Germany, 3Medical Department II, St. Vincent Hospital, the VINFORCE Study Group, Academic Teaching Hospital of Medical University of Vienna, Vienna, Austria, Vienna, Austria, 4Department of Medicine 3, Rheumatology and Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, 5Dept of Medicine 3, Rheumatology and Clinical Immunology, Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany, 6Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, 7Dept of Medicine 3, Rheumatology and Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, 8Institution de Rheumatologia, Sao Paolo, Brazil, 9Instituto de Reumatologia de Sao Paolo, Sao Paolo, Brazil, 10Rheumatology/Clinical Immunology, University of Würzburg, Würzburg, Germany, 11University of Freiburg, Freiburg, Germany, 12Rheumatologische Schwerpunktpraxis Erlangen, Erlangen, Germany, 13Schwerpunktpraxis Rheumatologie, Erlangen, Germany, 14Rheumatologie/Klinische Immunologie, Kreiskliniken Altötting-Burghausen, Burghausen, Germany, 15Department of Rheumatology and Clinical Immunology, Asklepios Medical Center Bad Abbach, Bad Abbach, Germany, 16Internal Medicine I, University Medical Center of Regensburg, Regensburg, Germany, 17Rheumatology Practice Bamberg, Bamberg, Germany, 18Rheumatology Practice, Bayreuth, Germany, Bayreuth, Germany, 19Rheumatology, University Heidelberg, Heidelberg, Germany, 20Rheumatology Practice Nuremberg, Nuremberg, Germany, 21Schlosspark-Klinik, University Medicine Berlin, Berlin, Germany, 22Department of Internal Medicine II, Division of Rheumatology, University Hospital Tuebingen, Tuebingen, Germany, 23Praxiszentrum St.Bonifatius, Munich, Germany, 24Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Department of Internal Medicine 3 – Rheumatology and Immunology, Universitätsklinikum Erlangen, Erlangen, Germany., Erlangen, Germany

    Background/Purpose: Achieving remission is the ultimate treatment goal in patients with rheumatoid arthritis (RA). With the development and wider use of highly effective disease modifying…
  • Abstract Number: 1052 • 2017 ACR/ARHP Annual Meeting

    Systematic Review of Modelling Approaches and Quality for the Cost Effectiveness of sequential Targeted Therapy in Patients with Rheumatoid Arthritis That Show an Inadequate Response to at Least One Tumor Necrosis Factor Alpha Inhibitor

    Aliza Matusevich1, Maria Suarez-Almazor1, Scott B. Cantor2 and Maria A. Lopez-Olivo1, 1Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA, Houston, TX, 2Department of Health Services Research, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA, Houston, TX

    Background/Purpose: Results from cost-effectiveness analysis (CEAs) comparing treatment options for patients with rheumatoid arthritis (RA) who have an inadequate response to an initial tumor necrosis…
  • Abstract Number: 1059 • 2017 ACR/ARHP Annual Meeting

    Cost-Effectiveness of Tai Chi Versus Physical Therapy for Knee Osteoarthritis

    John B. Wong1, Mei Chung2, Lori Lyn Price3 and Chenchen Wang4,5, 1Tufts Medical Center, Boston, MA, 2Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, MA, 3Biostatistics Research Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, 4Rheumatology, Center of Integrative Medicine and Division of Rheumatology, Tufts Medical Center, Boston, MA, Boston, MA, 5Division of Rheumatology, Tufts Medical Center, Boston, MA

    Background/Purpose: A single-blind randomized comparative effectiveness trial showed that Tai Chi yielded beneficial effects similar to those of a standard course of physical therapy in…
  • Abstract Number: 1080 • 2017 ACR/ARHP Annual Meeting

    Electronic Patient Reported Outcomes Increase Pediatric Rheumatology Clinic Operations Efficiency While Increasing Patient and Caregiver Satisfaction

    Y. Ingrid Goh1, Talia Goldberg2, Nicholas Lao3 and Brian M. Feldman4, 1Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, Canada, 2University of Toronto, Toronto, ON, Canada, 3University of Western Ontario, London, ON, Canada, 4Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada

    Electronic Patient Reported Outcomes Increase Pediatric Rheumatology Clinic Operations Efficiency While Increasing Patient and Caregiver SatisfactionBackground/Purpose: Patient reported outcomes (PROs) are powerful tools that facilitate…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 7
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences